首页>
外国专利>
PHARMACEUTICAL COMPOSITION COMPRISING A VANADIUM COMPOUND AND AT LEAST A COMPONENT SELECTED FROM A NA+/H+ EXCHANGER, CYCLO-OXYGENASE INHIBITORS AND CASPASE INHIBITORS
PHARMACEUTICAL COMPOSITION COMPRISING A VANADIUM COMPOUND AND AT LEAST A COMPONENT SELECTED FROM A NA+/H+ EXCHANGER, CYCLO-OXYGENASE INHIBITORS AND CASPASE INHIBITORS
展开▼
机译:包含钒化合物并至少选自NA + / H +交换剂,环氧化酶抑制剂和Caspase抑制剂的药物组合物
展开▼
页面导航
摘要
著录项
相似文献
摘要
Pharmaceutical composition for the prophylactic treatment of secondary injury of tissue, said secondary injury being induced by primary injury of mainly surrounding tissue and being the result of a traumatic event, wherein the pharmaceutical composition comprises a physiologically acceptable vanadium compound and at least a component selected from Na+/H+ exchanger inhibitors, cyclo-oxygenase inhibitors and caspase inhibitors, as active components. The pharmaceutical composition is preferably administered in a single dose and preferably before or immediately or shortly after the traumatic event.
展开▼
机译:用于预防性治疗组织继发性损伤的药物组合物,所述继发性损伤由主要周围组织的原发性损伤诱发并且是创伤事件的结果,其中所述药物组合物包含生理学上可接受的钒化合物和至少一种选自以下的组分Na + / H +交换抑制剂,环加氧酶抑制剂和半胱天冬酶抑制剂作为活性成分。药物组合物优选以单剂量给药,并且优选在创伤事件之前或之后或之后立即给药。
展开▼